ABSI
Absci Corp
NASDAQ · Healthcare · Biotechnology · US
$10.15
+1.50%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 80.35x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 7.08x
- Price / sales
- 1115.88x
- Price / cash flow
- -16.12x
Enterprise value
- Enterprise value
- $1.5B
- EV / sales
- 989.38x
- EV / EBITDA
- -14.05x
- EV / EBIT
- -11.76x
- Market cap
- $1.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026